MedPath

Marquis

Marquis®(15% w/w ponazuril)Antiprotozoal Oral Paste

Approved
Approval ID

888b1dde-fc9b-4022-b24b-7162da32e4e2

Product Type

PRESCRIPTION ANIMAL DRUG LABEL

Effective Date

May 1, 2025

Manufacturers
FDA

Boehringer Ingelheim Animal Health USA Inc.

DUNS: 007134091

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ponazuril

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0010-7314
Application NumberNADA141188
Product Classification
M
Marketing Category
C73593
G
Generic Name
ponazuril
Product Specifications
Route of AdministrationORAL
Effective DateMay 1, 2025
FDA Product Classification

INGREDIENTS (1)

ponazurilActive
Quantity: 150 mg in 1 g
Code: JPW84AS66U
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Marquis - FDA Drug Approval Details